Serum albumin is the most abundant protein in plasma and is highly sensitive to glycation,
leading to functional and structural alterations. These changes are subsequently involved in …

Various serum proteins, like Human Serum Albumin (HSA) and others, are susceptible to
glycation and the formation of Advanced Glycation End Products (AGEs). Diabetes and other …

The extraordinary ligand binding properties of albumin makes it a key player in the
pharmacokinetics and pharmacodynamics of many vital drugs. Albumin is highly susceptible …

In this study, we report the glycation mediated effect of bovine serum albumin (BSA) on the
molecular interaction mechanism of cyanidin-3-O-glucoside (C3G) by molecular modelling …

The non-enzymatic glycosylation is a very common phenomenon in the physiological
conditions which is mediated by distinct chemical entities containing reactive carbonyl …

Materials and methods Materials Bovine serum albumin (BSA) was obtained from
Sigma,(USA) and used for in vitro glycation studies using glucose and MGO. TRX, ThT …

Albumin glycation and subsequent formation of advanced glycation end products (AGEs)
correlate with diabetes and associated complications. Human Serum Albumin (HSA) was …

The drug binding ability of serum albumin might get affected as a result of its glycation under
diabetic conditions. It requires not only an understanding of the effect of glycation of the …

Hyperglycaemia is considered to be a driving factor for advanced glycated end products
(AGEs). Inhibiting the process of glycation play an important role in reducing the diabetes …

Background Glycation of serum albumin and its consequence products were considered as
an important factor in drug distribution and diabetic complications, therefore finding the …